Main Article Content



Pharmacovigilance plays a significant role in identifying adverse drug reactions (ADRs). In India, lack of knowledge regarding ADR reporting is one of the major causes for underreporting of ADRs. Hence the present study aimed to evaluate the knowledge, attitude and practice (KAP) among Pharm D students before and after educational intervention.


A cross-sectional and validated questionnaire-based study was conducted among Pharm D students to assess the level of KAP on Pharmacovigilance and ADR reporting and compared the same after the educational intervention. Scoring was done for the questions. Results were compared by t-test.


Among 197 participants 108 were male and 89 female. The improvement in knowledge related questions like functions, location of PvPI, WHO causality scales, timing of SAE(serious adverse event) reporting, methods employed by pharmaceutical companies to detect ADRs and people involved in reporting ADRs was statistically significant (p<0.01). Majority of the participants agreed that pharmacovigilance should be added in their curriculum and had come to know that there is no need to consult a physician before reporting.


In India, as Pham D is an emerging and clinically oriented course, educational interventions if held regularly, can help to improve knowledge and minimize underreporting of ADRs among healthcare professionals.


Adverse drug reaction Pharmacovigilance Educational intervention Pharm D students

Article Details

How to Cite
MeenakshiLella, SusmithaVemu, Meenakumari A, Triveni M, & Prashanthi. (2021). Educational intervention impact on pharmacovigilance and ADR reporting among Pharm D students. International Journal of Research in Pharmacology & Pharmacotherapeutics, 8(3), 311-316.


  1. [1]. W.Wu and N. Pantaleo, “Evaluation of outpatient adverse drug reactions leading to hospitalization,”American Journal of Health-System Pharmacy.60(3), 2003, 253–59.
  2. [2]. World Health Organization. International Drug Monitoring: The role of National Centers. Report of a WHO meeting. World Health Organ Tech Rep Ser. 498, 1972, 1-25
  3. [3]. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital--their severity and cost involved. Pharmacoepidemiol Drug Saf12, 2003, 687-9
  4. [4]. Singh H, Dulhani N, Kumar B, Singh P, Tewari P, Nayak K. A pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh (Jagdalpur), India. J Young Pharm. 2(1), 2010, 95-100
  5. [5]. Shuka SS, Bina G, Pandey R, Rao SP, Singh V, Amber V. Importance of Pharmacovigilance in the Indian Pharmaceutical Industry. Asian J Res Pharm Sci. 2(1), 2012, 4-6.
  6. [6]. Olsson S. The need for pharmacovigilance. In: Gupta SK. Pharmacology and Therapeutics in the New Millennium. New Delhi: Narosa Publishing House;2001, 502-8.
  7. [7]. World Health Organization. Safety of Medicine. A Guide for Detecting and Reporting Adverse Drug Reaction. Geneva: World Health Organization; 2002.
  8. [8]. PharmacovigilanceProgramme of India for assuring drug safety. Available from: [Last cited on 2019].
  9. [9]. Subish P, Mohamed Izham M, Mishra P. Evaluation of the knowledge, attitude and practices on adverse drug reactions and pharmacovigilance among healthcare professionals in a Nepalese hospital- a preliminary study. Internet Journal of Pharmacology 6(1), 2007.
  10. [10]. S. Prakash, “Pharmacovigilance in India,”Indian Journal of Pharmacology.39(3), 2007, 123.
  11. [11]. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2(5), 2006, 9, 385-96.
  12. [12]. Chopra D, Wardhan N, Rehan HS. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital. Int J Risk Saf Med23, 2011, 227‑32.
  13. [13]. Prasanna R. Deshpande, K. K. AhsanFarooq, Dijo M. John, E. JagadeshwaraRao. Pharm D: A new concept in India. J Pharm Bioallied Sci. 4(1), 2012, 84–86.
  14. [14]. Rishi RK, Patel RK, Bhandari A. Under reporting of ADRs by a medical practitioner in India‑results of a pilot study. AdvPharmacoepidemiolDrugSaf1, 2012, 112.
  15. [15]. Thomas TM, Udaykumar P, Scandashree K. Knowledge, attitude and practice of adverse drug reaction reporting among doctors in a tertiary healthcare centre in South India. Int J PharmacolClinSci2, 2013, 82‑8.
  16. [16]. Safety of Medicines: A guide to detecting and reporting adverse drug reactions (2002) World Health Organization
  17. [17]. Goel D. Impact of educational intervention on knowledge, attitude, and practice of pharmacovigilance among nurses. Arch Med Health Sci6, 2018, 32‑5.
  18. [18]. Ganesan S, Sandhiya S, Reddy KC, Subrahmanyam DK, Adithan C. The impact of the educational intervention on knowledge, attitude, and practice of pharmacovigilance toward adverse drug reactions reporting among health‑care professionals in a Tertiary Care Hospital in South India. J Nat ScBiol Med8, 2017, 203‑9
  19. [19]. SivadasanShalini and Sellappan Mohan. Knowledge and Attitude towards Pharmacovigilance and Adverse Drug Reaction Reporting among Dental Students in a Private University, Malaysia. Journal of Young Pharmacists7(2), 2015, 118-25
  20. [20]. Subish P, MahamedIzam MI, Mishra P, Shankar PR, Alam K. Education session for pharmacy students on pharmacovigilance. A preliminary study. J ClinDiagn Res4, 2010, 2427‑32.
  21. [21]. Raza A, Jamal H Assessment of Knowledge, Attitudes and Practice among the Medical and Pharmacy Students towards Pharmacovigilance and Adverse Drug Reactions in Abbottabad, Pakistan. J Pharmacovigilance3, 2015, 173-8